Study of Treosulfan-Based Conditioning for HSCT in Nijmegen Breakage Syndrome
Clinical trial NCT07316595 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07316595
- Sponsor
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2028-12-31
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.